Talking Precision Medicine

The Science and Art of De-risking Cancer Drug Development | Talking Precision Medicine #35

Listen Later

In this episode Genialis CEO Rafael Rosengarten sat down with Dr. Carolina Haefliger, head of translational medicine at Debiopharm, the privately held Swiss biopharma company focused on oncology drug development. They talked about de-risking promising new cancer drugs, and what it takes from the science to the team to the technologies.

Episode 35 links:

  • Visit ⁠⁠⁠TPM E35⁠⁠⁠ for highlights and links from this episode >
  • Learn more about Genialis™ krasID >
  • New Genialis RNA Biomarker Accurately Predicts KRAS Outcomes in Lung Cancer Patients >



    • ...more
    View all episodesView all episodes
    Download on the App Store
    Talking Precision MedicineBy Genialis
    • 4.7
    • 4.7
    • 4.7
    • 4.7
    • 4.7

    4.7

    7 ratings

    More shows like Talking Precision Medicine

    View all
    Science Weekly by The Guardian

    Science Weekly

    418 Listeners

    Hidden Brain by Hidden Brain, Shankar Vedantam

    Hidden Brain

    43,440 Listeners

    Pivot by New York Magazine

    Pivot

    9,284 Listeners

    The Daily by The New York Times

    The Daily

    110,845 Listeners

    The Readout Loud by STAT

    The Readout Loud

    316 Listeners

    Biotech 2050 Podcast by Biotech 2050

    Biotech 2050 Podcast

    61 Listeners

    The Prof G Pod with Scott Galloway by Vox Media Podcast Network

    The Prof G Pod with Scott Galloway

    5,418 Listeners

    All-In with Chamath, Jason, Sacks & Friedberg by All-In Podcast, LLC

    All-In with Chamath, Jason, Sacks & Friedberg

    9,243 Listeners

    BioCentury This Week by BioCentury

    BioCentury This Week

    30 Listeners

    Prof G Markets by Vox Media Podcast Network

    Prof G Markets

    1,161 Listeners